A decision model to compare health care costs of olanzapine and risperidone treatment for schizophrenia in Germany.
第一作者:
Stephen M,Beard
第一单位:
RTI Health Solutions, Manchester, UK. sbeard@rti.org
作者:
主题词
抗精神病药(Antipsychotic Agents);苯二氮|艹卓|类(Benzodiazepines);决策支持技术(Decision Support Techniques);德国(Germany);卫生保健费用(Health Care Costs);住院(Hospitalization);人类(Humans);质量校正寿命(Quality-Adjusted Life Years);复发(Recurrence);利哌立酮(Risperidone);精神分裂症(Schizophrenia);治疗结果(Treatment Outcome)
DOI
10.1007/s10198-006-0347-0
PMID
16896764
发布时间
2022-12-07
- 浏览20
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文